Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mitiglinide Calcium (KAD-1229) is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | In stock | $ 48.00 | |
200 mg | In stock | $ 68.00 |
Description | Mitiglinide Calcium (KAD-1229) is a blood glucose-lowering drugs, stimulating insulin secretion by closing the ATP-sensitive K+ channels in pancreatic beta-cells. |
Synonyms | KAD-1229, S21403 |
Molecular Weight | 668.88 |
Formula | (C19H24NO3)2·Ca |
CAS No. | 145525-41-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/mL (14.95 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mitiglinide Calcium 145525-41-3 Membrane transporter/Ion channel ATPase Potassium Channel S 21403 KAD-1229 type diabetes S21403 hypoglycaemic KAD 1229 KcsA insulinotropic anti-diabetic Inhibitor inhibit S-21403 KAD1229 Mitiglinide inhibitor